世界最新医学信息文摘（连续型电子期刊）
世界最新醫學信息文摘（連續型電子期刊）
세계최신의학신식문적（련속형전자기간）
World Latest Medicine Information
2015年
62期
190-190
,共1页
肺部占位%活检%气胸
肺部佔位%活檢%氣胸
폐부점위%활검%기흉
Thiracic disease%BioPsy%Pneunmothorax
目的：回顾性分析使用CT引导下经皮穿刺活检术行EGFR基因变异检测的并发症。方法对310例胸部实质性占位行CT引导下经皮穿刺活检术，结合诊断结果统计分析并发症。结果恶性肿瘤确诊率92.2%，假阴性率7.8%。良性病变确诊率94.6%、假阳性率4.4%。并发症气胸发病率12.9%，出血（咯血或胸腔积血>100mL）发生率为6.7%，同时合并出血和气胸发生率为5.2%。结论 CT引导下经皮胸部穿刺活检术应用于胸部实质性病变的EGFR检测是安全可靠的。
目的：迴顧性分析使用CT引導下經皮穿刺活檢術行EGFR基因變異檢測的併髮癥。方法對310例胸部實質性佔位行CT引導下經皮穿刺活檢術，結閤診斷結果統計分析併髮癥。結果噁性腫瘤確診率92.2%，假陰性率7.8%。良性病變確診率94.6%、假暘性率4.4%。併髮癥氣胸髮病率12.9%，齣血（咯血或胸腔積血>100mL）髮生率為6.7%，同時閤併齣血和氣胸髮生率為5.2%。結論 CT引導下經皮胸部穿刺活檢術應用于胸部實質性病變的EGFR檢測是安全可靠的。
목적：회고성분석사용CT인도하경피천자활검술행EGFR기인변이검측적병발증。방법대310례흉부실질성점위행CT인도하경피천자활검술，결합진단결과통계분석병발증。결과악성종류학진솔92.2%，가음성솔7.8%。량성병변학진솔94.6%、가양성솔4.4%。병발증기흉발병솔12.9%，출혈（각혈혹흉강적혈>100mL）발생솔위6.7%，동시합병출혈화기흉발생솔위5.2%。결론 CT인도하경피흉부천자활검술응용우흉부실질성병변적EGFR검측시안전가고적。
ABSTRACT:Objective Toevaluate the clinical aPPliationes of CT-guided Percutaneous needle bioPsy.Method:CT-guided Percutaneous needle bioPsy was Performed in 310 Patinets with thoracic diseases.We retrosPectively analyzed rhe Results and comPlications.Results:It was verified that the rate of correct diagnosis for the malignant tumour e was 92.2%,false negative rate was 7.8%.t was verified that the rate of correct diagnosis for benign tumour rate was 94.6%,false Positive rate was 4.4%. The comPlicatons of Pneunmothorax rate was 12.9%, The comPlicatons of bleeding rate(>100m) was 6.7%.the common comPlicatons rate was 5.2%.Conclusion:CT-guided Percutaneous needle bioPsy is an safey and reliability method in diagnosis of EGFR.
